Product Images Divalproex Sodium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Divalproex Sodium NDC 55154-4679 by Cardinal Health 107, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
bag label - bf6c7836 051e 4281 97c6 483901208c6f 00
This is a package of Divalproex Sodium Delayed-Release Tablets with NDC code 55154-4679-0. Each tablet contains 500mg of valproic acid. The package contains 10 tablets, and the usual dosage is described in the product insert. The package should be stored between 20-25°C. The package is not child-resistant and is intended for institutional use only. The drug product is from NDC # 57237-048, produced by Rising Health LLC., and packaged and distributed by American Health Packaging, a subsidiary of AmerisourceBergen Company. The package is distributed by Cardinal Health. A medication guide is included.*
bag label - bf6c7836 051e 4281 97c6 483901208c6f 01
This is a description of a medication called Divalproex Sodium delayed-release tablets. This pack has 10 tablets of 250mg each containing divalproex sodium USP equivalent to valproic acid 230g in enteric-coated delayed-release form. The drug is for Outpatient Use Only and must be kept out of reach of children. The package must not be used if already opened or has any sign of damage. The drug is dispensed with a medication guide for each patient. Storage instructions are provided on the package. The package is not intended for institutional use. The name of the manufacturer and distributor is also given. There are no non-English characters in the text.*
Figure 1 - divalproex fig1
Figure 2 - divalproex fig2
Figure 3 - divalproex fig3
Figure 4 - divalproex fig4
The text describes the mean 4-week migraine rates for two studies comparing the placebo to Divalproex Sodium delayed-release tablets. Study 1 used a mean dose of 1,087 mg/day while study 2 used a dose of either 500 or 1,000 mg/day.*
Chemical Structure - divalproex str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.